Purpose To review primary research evidence investigating performance of CT colonography for colorectal cancer surveillance. The financial impact of using CT colonography for surveillance was also estimated. Methods We identified primary studies of CT colonography for surveillance of colorectal cancer patients. A summary ROC curve was constructed. Inter-study heterogeneity was explored using the I2 value. Financial impact was estimated for a theoretical cohort of patients, based on Cancer Research UK statistics. Results Seven studies provided data on 880 patients. Five of seven studies (765 patients) were included for qualitative analysis. Sensitivity of CT colonography for detection of anastomotic recurrence was 95 % (95 % CI 62 − 100), specificity 100 % (95 % CI 75 − 100) and sensitivity for metachronous cancers was 100 %. No statistical heterogeneity was detected (I2 = 0 %). We estimated that CT colonography as a 'single test' alternative to colonoscopy and standard CT for surveillance would potentially save €20, 785,232 (£14,803,404) for an annual cohort of UK patients. Conclusion CT colonography compares favourably to colonoscopy for detection of anastomotic recurrence and metachronous colorectal cancer, and appears financially beneficial. These findings should be considered alongside limitations of small patient numbers and high clinical heterogeneity between studies. Key Points • CT colonography compares favourably to colonoscopy/ standard CT for colorectal cancer surveillance.
Background
Computed tomography (CT) colonography is an established technique for diagnosis of colorectal cancer, with detection rates for cancer and large polyps in symptomatic patients comparable to conventional colonoscopy [1] . CT colonography assesses colonic mucosa and extra-colonic organs, combining detection of luminal and extraluminal disease in the same diagnostic setting [2] . Colorectal cancer surveillance guidelines recommend interval assessment of the colon for luminal recurrence by colonoscopy, combined with additional review of extra-colonic organs (chest, abdomen and pelvis) for recurrent or metastatic disease, generally using CT [3, 4] . CT colonography could unite both aspects of surveillance, potentially decreasing cost and patient inconvenience. However, there are currently no published guidelines supporting such a role for CT colonography.
Intensive follow-up of patients after surgery for colorectal cancer likely confers survival benefit [5] [6] [7] with the timing of colonoscopic and radiological surveillance best determined by disease prognosis. In the UK, the National Institute for Health and Care Excellence (NICE) guidelines recommend a minimum of two CT scans of the chest, abdomen and pelvis within the first 3 years following surgery, and two surveillance colonoscopies within 5 years, with the first at 1 year [4] .
The purpose of this study was to systematically review primary research evidence supporting the use of CT colonography for colorectal cancer surveillance, potentially replacing colonoscopy and conventional CT with a single test. Assuming CT colonography is at least as accurate for detection of extra-colonic metastases as standard CT, we focused this review on efficacy of CT colonography for detection of anastomotic cancer recurrence and metachronous luminal cancer. We also estimated the potential financial impact of using CT colonography as an alternative single surveillance test in the UK NHS.
Methods
Ethical approval is not required by our institution for secondary research using existing available literature.
Definitions
In the absence of a universally accepted definition, the authors defined anastomotic recurrence as histologically confirmed recurrent cancer at or immediately adjacent to the primary anastomosis: ileo-colonic, colonic, colorectal or coloanal anastomosis depending upon site of primary tumour. This review did not categorise regional nodal recurrence as anastomotic recurrence. Metachronous luminal cancer is defined as cancer arising in the mucosa of colon or rectum not immediately adjacent to the anastomosis and not identified at the time of initial primary cancer surgery.
Inclusion criteria
To be eligible for inclusion, we stipulated that CT colonography findings were confirmed histologically from biopsy obtained by conventional colonoscopy, supplemented by peri-procedural knowledge of CT colonography findings (segmental unblinding technique [8] ), or the specimen from surgery. We also included studies where anastomotic recurrence was determined by a combination of unequivocal CT findings and elevated CEA, and with patients who had progressive anastomotic recurrence confirmed on serial imaging with CT and positron-emission tomography (PET)-CT, if these findings were felt to be unequivocal.
On the basis of generally accepted consensus guidelines for the CT colonography technique [9, 10] , all patients had to undergo bowel preparation (cleansing and/or faecal tagging) prior to examination. We stipulated data acquisition in two patient positions (usually prone and supine), with or without intravenously administered contrast. We stipulated CT colonography interpretation prior to the reference test or blind to reference test findings.
Data sources and search strategy
We wished to identify primary studies that combined CT colonography with surveillance of patients with colorectal cancer, and that reported the diagnostic test characteristics of CT colonography in this setting. A literature search of the MEDLINE, EMBASE and Cochrane databases was performed by two researchers (MU, GM). All primary studies for the period January 1994 (when CT colonography was first described) to November 2014 were initially eligible. The Medical Subject Headings ( M e S H ) t e r m s c o l o n o g r a p h y, c o l o g r a p h y, C T colonography, CT colonoscopy, CT pneumocolon, virtual colonoscopy or virtual endoscopy and/or the free-text terms CT comput* tomogra*, colonogra*, virtua* colonosc* and virtua*endosc* were used. These search terms were then combined with a search for surveillance protocols for patients treated for colorectal cancer using the MeSH terms BColorectal Neoplasms^and the free text terms Bsurveillance^or Bfollow-up^. We also handsearched the reference lists from search reports.
Study selection
Eligible studies investigated patient populations with colorectal cancer treated by surgical resection with curative intent. Patients underwent CT colonography as part of a follow-up protocol and detection of anastomotic recurrence or metachronous luminal cancer by CT colonography was recorded.
Articles included were those with fully documented surveillance data including absolute number of patients with anastomotic recurrence, and number of patients with anastomotic recurrence identified by both CT colonography and the reference test to enable calculation of pooled sensitivity and specificity.
Article titles and electronic abstracts obtained from the literature search were scrutinised by FP, MU and GM. After initial exclusions, full-text articles of the remaining studies were obtained and reviewed. Only fully published articles were eligible for inclusion to reduce heterogeneity. Systematic reviews, meta-analyses and articles not in the English language were excluded.
Data extraction and analysis
Three reviewers (FP, MU and GM) independently assessed included studies and extracted data into an electronic database, with disagreements resolved by face-to-face consensus with a fourth reviewer (DB). From each eligible study, the following were extracted: publication year, study type (single or multicentre design, retrospective or prospective), stage and site of colorectal cancer, type of bowel preparation used, interpretation strategy for CT colonography (primary 2D or 3D review), faecal tagging, use of intravenously administered smooth muscle relaxant (hyoscine butylbromide or glucagon), use of intravenously administered contrast medium, radiation dose, reader experience, reference standard, and surveillance protocol (follow-up duration and temporal intervals between scans).
Patient characteristics, study design, CT colonography technique, observer experience and viewing mode were tabulated and analysed with descriptive statistics informed by the Quality Assessment of Diagnostic Accuracy Studies version 2, or QUADAS-2. QUADAS-2 is a tool developed to assess risk of bias and relevance, or 'applicability', to the review question, using a series of tailored signalling questions [11] . The signalling questions aim to highlight concerns regarding patient selection, use of the index and reference tests, and of flow or timing within each study. Results of the QUADAS-2 assessment were converted into a summary score of 'high risk', 'low risk' or 'unclear' for each category (Table 1) .
Per-patient 2 × 2 contingency tables were constructed for meta-analysis of sensitivity and specificity of CT colonography for detection of anastomotic recurrence and metachronous luminal cancer. A bivariate model was used to construct a summary receiver operating characteristic (ROC) curve for the included studies. Forest plots of sensitivity and specificity were generated using a random-effects model. Inter-study heterogeneity was explored using the Chi-square statistic and the I 2 value (I 2 < 25 % low, I 2 = 25-75 % moderate and I 2 > 75 % high heterogeneity). Publication bias was assessed by searching for asymmetry of the funnel plots. Calculations were performed by MU and GM and verified by ODF and TA (see Appendix). This study was performed according to Cochrane recommendations, following MOOSE guidelines [12] , using appropriate statistical software (STATA, version 14, manufactured by StataCorp LP, College Station, TX, USA).
Financial impact
We estimated the potential diagnostic costs of the currently used colorectal cancer surveillance programme compared with a programme based on CT colonography alone. Costs were estimated for surveillance years 1 and 5, using a cohort based on current Cancer Research UK statistics, adjusted for known 1-and 5-year survival rates [13] . The reported incidence of colorectal cancer in the UK in 2011 was 41,581 [14] but not all patients would undergo post-surgical surveillance, such as those deemed too physically unfit for surgery, or when CT colonography surveillance is deemed inappropriate, for example those with familial polyposis or ulcerative colitis. Taking these factors into account, we considered a figure of 35,000 patients per annum could reasonably represent a postsurgical cohort. However, the current reported overall survival rates for colonic cancer are 74 % at year 1 and 58 % at year 5 [13] , and so we used the figures of 25,900 and 20,300 to represent the number of surviving patients who might undergo colonoscopic follow-up at years 1 and 5.
Unit costs for individual diagnostic procedures were obtained from the NHS National Tariff for 2014/2015 [15]: a contrast-enhanced CT of the chest, abdomen and pelvis costs £127, plus £28 for issuing a report. This price is then adjusted according to the Market Forces Factor (MFF), which at the London North West Hospitals Trust is 19.6 % (at the time of writing in May 2015), bringing the total unit cost to £185.38 at our institution.
The tariff for colonoscopy is £446 (without biopsy). We combined this with the cost of a CT chest, abdomen and pelvis to arrive at the combined cost of £631.38 for surveillance.
Currently, CT colonography is not listed separately on the national tariff, with reimbursement varying at different sites due to service level agreements. We classified CT colonography as a 'three-area' scan due to its increased procedural complexity, i.e. an equivalent cost to CT chest, abdomen and pelvis of £185.38. The cost for contrast-enhanced CT chest is £85, plus £20 reporting cost, multiplied by 19.6 % MFF, totalling £125.58.
Results

Study selection
After removal of duplicates, 1,554 individual citations were identified by the systematic literature search. Of these, 1,469 were excluded following abstract review, leaving 85 articles for retrieval. Subsequent full-text review resulted in the identification of seven primary studies [16] [17] [18] [19] [20] [21] [22] describing the use of CT colonography for surveillance of colorectal cancer that were eligible for inclusion. A flowchart of the literature search and extraction is shown in Fig. 1 .
Of the seven studies identified, one performed conventional colonoscopy and CT colonography in patients in whom there was an 'a priori' high clinical suspicion of recurrent disease, evidenced by blood in the stools, symptoms of bowel obstruction, palpable abdominal mass or raised serum CEA [16] . As a result, their data showed a disproportionally high number of 51 local recurrences (64 %) from a total 80 patients. Because of this selection bias and our concerns that the reported study population did not match the review question, we excluded this study from quantitative analysis, although we included it for discussion. One further study described ten patients (ten of 50; 20 %) for whom there was a high clinical suspicion of recurrent disease with raised serum CEA [17] . Additionally, one study [18] did not report any true positive cases for CT colonography or the reference test, preventing quantitative analysis as the statistical model will not run if there are no positive cases identified, therefore this study could not be included in the quantitative analysis. = low risk of bias/low concern regarding applicability, = high risk of bias/high concern regarding applicability, ? = unclear from manuscript. Based on: Whiting PF, Rutjes AWS,Westwood ME et al. 
Characteristics of included studies
The seven selected studies totalled 880 patients. Six studies were prospective [16] [17] [18] [19] [20] [21] and one retrospective [22] , and all were single-centre observational cohort studies. The overall surveillance interval ranged from 6 to 60 months. It was not possible to determine an overall mean surveillance interval due to inadequate data; for example, two studies listed interval ranges only [19, 21] . Four studies had mean follow-up intervals of 36, 25.3, 32 and 12 months [16] [17] [18] 20] . One study had a median interval of 24 months between surgery and CT colonography [22] . Surveillance CT colonography was repeated during the surveillance period in 14 of 53 patients in one study [19] . Only one of the seven studies detailed their patient selection method as chronologically consecutive [22] .
No study specifically defined 'anastomotic recurrence' or 'metachronous luminal cancer' and so the authors of this review (FP/MU) applied the definitions described above to the articles' text description of findings. This process was considered to accurately confirm 'anastomotic recurrence' or 'metachronous luminal cancer' for patients in five of the seven studies, although not accurately for three patients in two studies [19, 20] . We have sought clarification directly from the corresponding authors of these studies (no communication received back by the time of submission). One of the documented recurrences was sufficiently vague to warrant exclusion of this patient from the qualitative analysis [20] .
Two studies excluded patients with end or diverting colostomies [16, 17] . One study does not describe prior clinical suspicion for recurrent disease (for example no published carcinoembryonic antigen levels) [19] . Three studies did not specify exclusion criteria [18, 20, 21] .
All included studies used intravenous contrast and multidetector row CT scanners, with reconstruction intervals ranging from 1 to 3 mm, and fulfilled our stipulations for CT colonography examination technique (Table 2) .
Variation in the reported location and staging of primary cancer was noted between studies. One study [19] Abbreviations for location of disease: Ce cecum, RC right colon, TC transverse colon, LC left colon, SC sigmoid colon, R rectum, A anus, Sync two synchronous cancers five cases of cancer located at the 'anus'. Three studies did not specify the location of primary colorectal cancer [16, 17, 20] . Five of the seven studies described the stage of disease using different staging methods (Dukes, TNM and AJCC-UICC) [16-18, 21, 22] . Colonoscopy was the reference standard in all seven studies with the reference enhanced by surgery in three studies [16, 17, 19] .
One study confirmed an anastomotic recurrence in one patient based on unequivocal CT findings and clinical evidence of recurrence with raised CEA [17] , and another study confirmed an anastomotic recurrence on serial imaging with CT and PET-CT [20] .
In two studies colonoscopy was not blinded to the results of preceding CT colonography [21, 22] . Three studies used blinded colonoscopy [16, 18, 20] , with one utilising segmental unblinding [20] . In one study it was unclear whether colonoscopists were blinded or not [17] . One study performed colonoscopy prior to CT colonography [19] , with reporting radiologists blinded to colonoscopy findings.
The time interval between CT colonography and conventional colonoscopy is stipulated in four studies [16] [17] [18] 20] as between 0 and 7 days for all patients except one who had colonoscopy 3 weeks after CT colonography [17] . This time interval is not specified in three studies [19, 21, 22] .
One study detailed radiologist experience in approximate numbers of CT colonography examinations reported [22] ; three simply described their radiologists as 'experienced' [16] [17] [18] ; and three did not mention radiologist experience [19] [20] [21] .
The QUADAS-2 summary of study quality is presented in Table 1 . A summary of study characteristics is provided in Table 2 . Study results are depicted in Table 3 .
Performance characteristics of CT colonography
CT colonography correctly identified 18 of 19 patients (95 %) with anastomotic recurrence. Our analysis found an average sensitivity of 95 % (95 % CI 62-100) and specificity of 100 % (95 % CI 75-100) for detection of anastomotic recurrence with CT colonography, with the summary ROC curve close to the top left corner of the ROC plot (Fig. 2) . Summary performance estimates are displayed in Table 4 . Study heterogeneity is low (I 2 = 0 %), as summarised in the forest plots (Fig. 3) .
Notably, three of 19 (16 %) anastomotic recurrences were missed by conventional colonoscopy [17, 19, 20] whereas only one recurrence was missed by CT colonography [19] .
Ten metachronous luminal cancers were identified on CT colonography; three studies each identified one metachronous cancer [16, 19, 21] ; one study identified six metachronous cancers [22] ; and one study identified one carcinoma in situ [18] . There were no false negatives for metachronous cancers detected by CT colonography.
Two of seven studies reported CT colonography with sensitivity of 100 % for detecting anastomotic recurrence [16, 17] , and a third study reported sensitivity of 100 % for detecting both anastomo tic recurrence and metachronous luminal cancer, with a negative predictive value of 100 % [22] . The remaining four studies do not specifically report negative predictive value or sensitivity. Two of seven studies reported specificity of 83 % [16] and 94 % [17] for anastomotic recurrence detected by CT colonography. Sixteen patients were incorrectly categorised as having anastomotic recurrence (false positives) by CT colonography. Positive predictive values were not reported by any of the studies. 
Financial impact
Presently, the follow-up unit costs using combined colonoscopy and CT chest, abdomen and pelvis total £29,169,756 at year five, assuming 2 years of follow-up (£16,352,742 for 25, 900 patients at year one and £12,817,014 for 20,300 patients at year five). Using CT colonography (including chest CT, total £310.96) alone provides a comparative cost of £14,366, 352 (£8,053,864 at year one and £6,312,488 at year five), potentially saving £14,803,404 (€20,785,232).
Discussion
Our systematic review and meta-analysis has estimated that CT colonography compares favourably to colonoscopy for detection of anastomotic recurrence or metachronous luminal cancer. CT colonography correctly identified 18 of 19 patients (95 %) with anastomotic recurrence. The study describing the 'missed anastomotic recurrence' also describes the recurrence as visible on 'axial CT', and therefore we have sought to clarify from the corresponding author whether this was truly a false negative for 'CT colonography' [19] . This uncertainty emphasises the need for clarity around CT colonography terminology and which protocols are used.
Three of 26 (12 %) anastomotic recurrences were missed by conventional colonoscopy. In two studies these are described as 'extraluminal' recurrences [17, 20] and in one study it is unclear whether the recurrence had a luminal component [19] . Anastomotic recurrence may or may not have a luminal component depending upon the relationship of the origin of recurrent tumour to the mucosa.
The potential saving of £14,803,404 must be considered alongside the number of patients with positive luminal findings identified by surveillance CT colonography who will be referred subsequently for assessment by colonoscopy. Studies included in this review had highly variable referral rates from CT colonography to colonoscopy of 14-66 % [18, 20, 22] at 1-year follow-up. These rates appear very high and include patients in whom polyps have not been cleared by colonoscopy or surgery prior to surveillance colonoscopy. There is a paucity of published data revealing the percentage referral rate from CT colonography surveillance to colonoscopy in the setting of high quality colonoscopy and initial clearance polypectomy.
There is considerable variation in colorectal cancer surveillance strategies between colorectal teams with many electing for more intensive follow-up than NICE [4] recommends as emerging evidence supports early detection and treatment of recurrent disease [7, [23] [24] [25] . Demand for more intensive surveillance would require considerable additional resource which could be offset by substituting both tests for CT colonography.
Our systematic review has several limitations: The number of included studies is small, and six studies had small numbers of patients; there is a high risk of patient selection bias; variable reference standard; variable intervals between surgery and surveillance test (up to 60 months) ( Table 3) ; clinical heterogeneity between the studies is high.
Our financial analysis is relatively crude and based on differences in unit costs between current surveillance practices versus CT colonography alone. We have not taken into account the small number of false positives found in the individual studies at CT colonography.
In conclusion, this review provides data supporting the utility of CT colonography as a potentially cost-saving alternative to standard surveillance protocols (combining colonoscopy and standard CT). However, a more rigorous prospective, multicentre study with formal cost-effectiveness analysis would be required prior to any population-wide change in colorectal cancer surveillance strategies. 
